4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-005256
Options or other derivatives
- Chief Executive Officer acquired 3,077,328 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Rawcliffe Adrian Chief Executive Officer | 2020-01-16 | Grant or award · Option to purchase Ordinary Shares | +2,515,536 | 2,515,536 | D | ||
| Rawcliffe Adrian Chief Executive Officer | 2020-01-16 | Grant or award · Option to purchase Ordinary Shares | +561,792 | 561,792 | D | ||
Loading xslF345X03/a4.xml…